Table 3.

Risk ratios for any types of cancer, lymphoma and liver, colon, lung, and bladder cancer in type 2 diabetic patients with dipyridamole or aspirin use.

	Dipyridamole		Aspirin
	AHR (95% CI)	P value	AHR (95% CI)	P value
Any types of cancer	0.82 (0.65–1.04)	.1088	0.72 (0.59–0.89)	.0026
All-cause mortality	0.94 (0.72–1.23)	.6595	1.08 (0.85–1.37)	.5203
Liver cancer	0.51 (0.32–0.80)	.0037	0.46 (0.31–0.69)	.0001
Colon cancer	0.82 (0.36–1.90)	.6463	0.67 (0.31–1.44)	.3004
Lung cancer	0.68 (0.34–1.36)	.2803	0.77 (0.43–1.38)	.3734
Bladder cancer	2.14 (0.59–7.85)	.2501	0.53 (0.13–2.24)	.3899
Lymphoma cancer	0.35 (0.06–1.95)	.2309	0.11 (0.01–0.96)	.0455

All model adjusted variable in Table 1.

AHR = adjusted hazard ratio, CI = confidence interval.